Pennsylvania Pulls Flavored Vapes From Market

It seems Pennsylvania’s medical marijuana program has pulled flavored vapes. Last week, On February 2, 2022, the Pennsylvania Department of Health (DOH) posted a list of known additives that it says were not approved by the FDA (Food & Drug Administration) for inhalation. Then on Friday February 4, 2022, the Pennsylvania DOH issued a withdrawal of these products by many of the leading cannabis companies in the state. The products mostly seem to include flavors like citrus, candies and cookies.

The DOH sent a letter to patients and caregivers on February 4th saying that some of the additives were approved by the FDA in  non-inhalable products, but were not approved for inhalable products. They issued a mandatory recall for all the products.

The companies included on the list were:

  • AES Compassionate Care
  • Agri-Kind
  • CannTech PA
  • Cresco Labs
  • Curaleaf (OTC: CURLF)
  • FarmaceuticalRX
  • Franklin Labs
  • Greenleaf Medical
  • Goodblend Pennsylvania
  • GTI Pennsylvania (OTC: GTBIF)
  • Holistic Farms
  • Ilera Healthcare
  • Insa
  • MLH Explorations
  • Pennsylvania Medical Solutions
  • PennAlt Organics
  • PurePenn

One company not on the list was Tilt Holdings (OTC: TLLTF), which wasted no time in letting the market know it wasn’t included.

“We have always been intently focused on manufacturing products that are safe, consistent, and effective for our patients,” said CEO Gary Santo. “While we do not have enough information available to comment on the DOH’s stance with respect to the use of certain additives, we want to make it clear to our patients, investors and other stakeholders that none of our products were named in the recall. TILT will continue to support our brand partners and other cannabis operators as the regulated industry seeks a resolution that prioritizes product conformance to the new additive restrictions released by the Pennsylvania DOH on Friday.”

Pittsburgh Business Times reported that since 2018, “There have been $2.8 billion in total sales, including $1.1 billion from growers and producers to dispensaries and $1.7 billion from the dispensaries to more than 582,000 registered patients and caregivers.”

 

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 36 mins

Researchers Seek to Remove ‘Trip’ as Popularity of Psychedelic Treatments Grows

@GreenMarketRpt – 3 hours

The Weekly Stash Video September 30, 2022

@GreenMarketRpt – 3 hours

Florida Drops Criminal Charges Against Former Ascend Wellness Chief

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.